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Abstract
Background: Recent epidemiological data show an increased trend of official estimates for syphilis
infection in the general population. Many of the infected cases remain undetected leaving an
underestimation of the true prevalence of syphilis in the general population, but also among
subpopulations such as illicit drug users. There is limited epidemiological data published on the
proportion and risk factors of syphilis infections associated with illicit drug abuse.
Methods: Illicit drug addicts (n = 1223) in inpatients units in Germany were screened (2000–01)
for syphilis and interviewed regarding patterns of drug use and sexual behaviour. TPHA-test for
initial screening and FTA-ABS-IgM test in TPHA-positive patients were used.
Results: In total, TPHA-tests were positive in 39 (3.3%) and 7 patients (0.6%) were IgM positive.
The prevalence rate for syphilis in males was 1.9% and for women it was 8.5%. Female patients were
4.56 (CI 95% 2.37–8.78) times more likely to have a positive TPHA test than males. Sexual
behaviours such as high number of sexual partners, sex for drugs/money, sex on the first day were
associated with syphilis infection only in women. Females with frequent sex for drugs or money
had 4.31 (CI 95% 2.32–8.52) times more likely a reactive TPHA test than remaining patients.
Neither the sociodemographic factors nor sexual behaviour were statistically significant associated
with syphilis infection among men at all.
Conclusion: Our data suggest the need for screening for syphilis among these illicit drug users in
inpatient settings, in particular among sexual active women. This conclusion is corroborated by the
finding of increasing numbers of syphilis infections in the general population. The identification of
syphilis cases among drug addicts would give treatment options to these individuals and would help
to reduce the spread of infection in this population, but also a spread into heterosexual populations
related to prostitution.
Published: 17 May 2005
BMC Infectious Diseases 2005, 5:33 doi:10.1186/1471-2334-5-33
Received: 16 March 2005
Accepted: 17 May 2005
This article is available from: http://www.biomedcentral.com/1471-2334/5/33
© 2005 Scherbaum et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 6
(page number not for citation purposes)
BMC Infectious Diseases 2005, 5:33 http://www.biomedcentral.com/1471-2334/5/33Background
World-wide, the incidence and prevalence of syphilis dif-
fer due to region, ethnic factors, gender and socio-eco-
nomic factors [1-5]. In the 90s the yearly incidence of
syphilis in Germany decreased to 1.4 cases / 100,000
inhabitants according to official numbers. However, a
sentinel surveillance conducted in 1994 showed that 84%
of the syphilis cases were not reported and thus, the real
incidence could be as much as six times higher [5]. More
recently an inverse trend of official estimates was observed
with incidence increased to 3.1 cases / 100,000 inhabit-
ants in 2002, but the increase was related only to infec-
tions acquired in the sample of men who have sex with
men [6].
There are few epidemiological data published on the pro-
portion of syphilis infections associated with illicit drug
abuse. According to reports from the USA, drug addicts,
especially injecting drug users (IDU), are a high-risk group
for syphilis infection [7]. Gourevitch et al. reported 1996
a six year follow-up investigation of 790 opiate addicts in
methadone maintenance treatment. In their study, 4.4%
of the study subjects had antibodies against syphilis, and
the yearly incidence of that infection was 5.7 per 1000 [7].
The prevalence of syphilis in the sample of opiate drug
addicts in Germany is not reported so far. Along with
abandoned general screening strategies for syphilis at
admission to general psychiatric departments [8], screen-
ing for syphilis at admission to detoxification wards is no
longer clinical routine in most German hospitals, despite
severe complications of untreated syphilis [9,10].
Objectives
The goal of our study was to estimate the prevalence of
syphilis in the population of illicit drug addicts, mainly
opiate addicts, admitted to detoxification wards in psychi-
atric hospitals. Furthermore, risk factors associated with
syphilis infection were investigated to identify individuals
at high risk for syphilis infection in this population.
Methods
Study population
Our study was performed at detoxification wards for drug
addicts in eight hospitals in the federal state of North
Rhine-Westphalia, Germany. Overall, from 1529 eligible
patients admitted to any of these detoxification wards
during a two years period (2000–2001) 1309 patients par-
ticipated in the study. Of these patients 86 (7%) individ-
uals left hospital within less than 24 hours or were
recurrent admissions and were excluded. Finally, there
were 1223 patients in the study, which accounted for an
overall response rate of 80%.
All patients were interviewed by physicians using a stand-
ardised questionnaire and subsequently tested for syphilis
infection. The topics of the questionnaire were: patterns of
drug use, sexual risk behaviour and known infection sta-
tus for Treponema pallidum (syphilis), HIV, Hepatitis B-
virus (HBV) and Hepatitis-C-virus (HCV), or Neisseria
gonorrhoeae (Gonorrhoea). In addition, sociodemo-
graphic data were obtained including country of birth (or
ethnic origin) and time of immigration to Germany. The
study was approved by the local ethics committee of the
University of Essen, Germany, and all patients gave
informed consent for participation in the study. Patients
identified with active syphilis obtained a standard treat-
ment for syphilis. Penicillin G was applied intravenously
due to unknown state and duration of the syphilis infec-
tion [11] and potential simultaneous HIV-infection. [12].
Microbiological testing
German syphilis screening guidelines allow for a two stage
testing procedure [11]. Firstly, we used the TPHA as a
screening test for Treponema pallidum (Mast TPHA kit,
Mast Laboratories, UK). According to producer informa-
tion the sensitivity of this test is 98.2%, the specificity is
99.7% [13,11]. Secondly, patients with reactive TPHA test
were tested using a FTA-ABS IgM-test for confirmation of
positive Treponema pallidum. Thus, patients with posi-
tive TPHA and FTA-ABS IgM were considered in need of
treatment (excluding cases with already initiated treat-
ment before admission). Patients with positive TPHA but
negative FTA-ABS IgM were considered either as success-
fully treated (if there was history of treatment) or as spon-
taneously recovered from the infection (if there was no
history of treatment). VDRL tests were carried out in
treated patients to evaluate treatment effects after 3, 6, and
12 months [11]. These follow-up results were not consid-
ered in the study.
Data analysis
Data were entered and analysed with SPSS, Version 11.0
[14]. The prevalence of syphilis infection was determined
by calculating the ratio of TPHA-test positives and all
tested drug addicts stratified for gender. Risk factors asso-
ciated with syphilis infection were analyzed by the use of
logistic regression analysis adjusted for age and gender.
Results
Characteristics of the sample
In total, 1223 illicit drug addicts with a mean age of 30.1
years participated in the study of which 951 were males
(77.8%) and 272 females (22.2%). 991 patients (81.6%)
were born in Germany.
Nearly all (n = 1186; 97%) of the study population were
opiate addicts. The length of opiate addiction in the sam-
ple ranged between 1 month and 37 years with the
median of 8 years, and there was a relatively equal propor-
tion of users with 1, 2 or 3 (up to 10) years history of use.Page 2 of 6
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treatment program at admission with a duration of 2 years
(SD 2.1)) on average. 1068 (87.5%) patients reported her-
oin abuse in the last three months, the majority of them
(n = 654) by i.v.-injection. Recent cocaine abuse was
reported by 612 patients (55.4%), mostly intravenously
(n = 403). A stable partnership over the last year before
admission was reported by 265 (21.7%) patients.
Self-reported infection status and sexual behaviour
A known Hepatitis-C-infection was reported by 65.4% of
the subjects, 26.9% knew of a previous Hepatitis-B-infec-
tion, 2.3% reported being HIV-positive, 2.4% admitted
having had at some time gonorrhoea, and 2.5% reported
a former or current syphilis-infection. According to the
self-reported sexual behaviour in our sample in table 1, a
higher proportion of female (22.7%) than male (4.5%)
participants had frequently sex in exchange for drugs or
money. Frequent sex on the first day of meeting a partner
was also more frequent in females (18.9%) than in males
(2.2%). This type of sexual behaviour indicates a higher
proportion of prostitutes among females than males
(table 1).
Table 1: Sero-prevalence of syphilis antibodies (according to TPHA-Test) among inpatient drug addicts by gender, sociodemographic 
factors and sexual behaviour
Male Female
N with test % with reactive TPHA 
-Test
P N with test % with reactive TPHA 
-Test
p 1
Overall 890 1.9 259 8.5
Age groups 0.55 0.05
below 21 years 56 1.8 23 13.0
21–30 years 406 1.7 128 6.3
31–40 years 356 1.7 80 6.3
over 40 years 72 4.2 28 21.4
Illicit drug abuse 0.28 0.13
no or <2 y 91 4.4 33 0
2 to 4 y 193 1.0 45 6.7
5–7 y 106 1.9 31 16.1
>7 y 500 1.8 150 9.3
Migration background 0.184 0.374
Native German 694 1.6 233 9.0
Migrants 196 3.1 26 3.8
Stable partnership 0.60 0.60
no or <1 year 558 1.8 142 9.9
1 to 4 years 171 1.2 72 8.3
≥ 5 years 150 2.7 41 4.9
Number of sexual partners in the last 5 years 0.61 0.00
0–1 247 1.6 49 2.0
2–5 315 2.2 86 3.5
6–20 192 1.0 33 0
>20 136 2.9 91 19.8
Sex for drugs/money 0.52 0.00
never 826 1.8 147 2.7
seldom 22 0 30 0
frequent 22 4.5 75 22.7
Sex on the first day 0.89 0.00
never 502 1.6 120 1.7
seldom 215 1.9 41 2.4
frequent 137 2.2 90 18.9
Condom use with risky partner 0.53 0.01
never 232 1.3 73 1.4
up to half of the cases 166 1.2 34 2.9
in 3/4 of the cases 33 0 14 21.4
nearly always 182 1.6 73 15.1
no risky intercourse 236 3.0 52 7.7
p-value of chi square test or Fisher's exact test, respectively;Page 3 of 6
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TPHA-testing was carried out in 1181 patients of which 39
(3.3%) tests were positive (female n = 22; male n = 17).
The distribution of TPHA positive cases ranged from 0%
to 8.6 across the 8 participating hospitals. In 24 out of the
39 TPHA-positive cases (61.5%), patients were aware of a
former syphilis infection. In 6 cases a former syphilis
infection was reported by the patient but the TPHA-test
was not reactive. The specific IgM-test for current infection
was positive in 7 out of the 39 TPHA-positive cases (0.6%
of all tested patients), indicating current syphilis infection
(female n = 4; male n = 3). Five out of these 7 patients
were not aware of their current infection. Nine out of 32
TPHA positive but FTA-ABS IgM-negative patients did not
know about an earlier infection (29%, 3 of 14 men and 6
of 18 women).
Prevalence of syphilis
The proportion of patients with reactive TPHA is pre-
sented in Table 1 showing results stratified for gender.
Women had a 4.56 (95% CI 2.37–8.78) times higher risk
for a reactive TPHA-test than men. Furthermore, women's
sexual behaviour, such as high numbers of sexual part-
ners, sex for drugs/money, and sex on the first day, was
associated with syphilis infection. Contrary, none of the
figures for men in Table 1 showed any statistically signifi-
cance. Condom use in men indicated no clear trend for
risky or healthy practice, in contrast to women who
mostly used condoms at sexual intercourse. The duration
of the methadone maintenance program (MMTP) showed
no statistically significant difference (p = 0.41) between
patients with reactive TPHA (mean duration of MMTP 2.4
y, SD 2.8) and those without reactive TPHA (mean dura-
tion of MMTP 2.0 y, SD 2.1).
Table 2: Association of sociodemographic factors, clinical parameters and sexual behaviour with syphilis infection among 1223 drug 
addicts
Syphilis infection (positive for TPHA)
OR* 95%CI p-value
Gender
Male 1 [reference group] <0.00
Female 4.56 [2.37–8.78]
Age groups
below 21 y 1 [reference group]
21–30 y 0.59 [0.19–1.85] 0.363
31–40 y 0.59 [0.18–1.94] 0.383
over 40 y 1.94 [0.56–6.71] 0.295
Illicit drug abuse
no or <2 y 1 [reference group]
2 to 4 y 0.89 [0.23–3.53] 0.872
5–7 y 1.88 [0.52–6.79] 0.334
>7 y 0.96 [0.32–2.92] 0.945
Migration background
native German 1 [reference group]
Migrants 1.51 [0.63–3.62] 0.36
Stable partnership
> 5 years 1 [reference group]
1 to 5 years 1.17 [0.46–2.97] 0.94
<1 year 1.04 [0.35–3.16] 0.74
Number of sexual partners in the last 5 years
0–1 1 [reference group]
2–5 1.71 [0.57–5.17] 0.34
6–20 0.69 [0.13–3.67] 0.67
> 20 5.85 [2.07–16.5] 0.00
Sex for drugs/money
never 1 [reference group]
frequent 8.81 [3.66–21.19] 0.00
Sex on the first day of meeting a partner
never 1 [reference group]
seldom 1.31 [0.44–3.9] 0.63
frequent 4.98 [2.22–11.19] 0.00
OR denotes Odds ratio; CI denotes confidence interval; *adjusted for sex and age (where appropriate)Page 4 of 6
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Table 2 presents a logistic regression analysis for the asso-
ciation between sociodemographic and behavioural
parameters and syphilis infection. Apart from gender, no
other demographic factor such as age or ethnic back-
ground showed any statistically significant associations
with syphilis infection. Sexual behaviour was related to
infection status as regular sex on the first day meeting a
partner and high numbers of sexual partners were statisti-
cally significant associated with syphilis infection. Since
risk factors differed between women and men, we strati-
fied the results by gender. There were no consistent effects
of age or drug abuse history on risk for reactive TPHA
apart from an increased risk for older women. Sexual
behaviour was associated with an increased risk for syph-
ilis infection in women but not in men; however, even
within women the increased risk was limited to women
with regular sex for drugs. Females with frequent sex for
drugs or money had 4.31 (CI 95% 2.32–8.52) times more
likely a reactive TPHA test than remaining patients. Fre-
quent sex on the first day of meeting a partner was statis-
tically significant associated with syphilis infection in
females (OR 17.8; 95%CI, 3.8–83.38), but not in males
(OR 1.43; 95%CI, 0.37–5.5). There was an increased risk
in women who used condoms more consistently, but after
adjustment for regular sex for drugs this effect was not sig-
nificant any more (not shown). No gender differences
were found for the association of syphilis infection and
migration or the existence of a stable partnership,
respectively.
Discussion
The sero-prevalence of syphilis (according to TPHA) of
3.3% in our study is comparable to the findings of studies
carried out in the USA among drug abusers in treatment
facilities [7,15,16], but it is much lower than 23% among
injecting drug users in Bangladesh [17]. However, only 1
in 5 of the TPHA positive patients in our study (0.6% of
all screened patients) was in need of treatment, all other
patients were already treated or recovered from the dis-
ease; these proportions were not reported for the other
countries and may significantly differ.
According to our results, women were more often affected
than men; the risk was especially increased in women hav-
ing commercial sex. A study among IDUs in Spain showed
a 4 times higher prevalence of syphilis and other STDs
among women than men [16]. Similar to our results,
syphilis was associated in this study with commercial sex
in women.
We could not identify any significant risk factors for syph-
ilis in male IDUs in our sample. We neither found a
higher risk in immigrants nor in HIV positive patients. An
increased risk for syphilis among immigrants especially
from East European countries has been expected based on
the reports of a higher prevalence of syphilis in these
countries [18]. Although in our study about one third of
immigrants (75 out of 205) came originally from the
former USSR, no increased risk for syphilis was detected
for this group. In our study intravenous drug use (heroin
or cocaine) was not a proven risk factor for previous or
current syphilis infection, whereas it was observed in the
study by Rolfs et al. [19].
Contrary to our results an Italian study on heroin addicts
with a 6-year follow-up period did not find any cases of
syphilis infection [20]. The possible explanation for this
difference is the higher proportion of patients with past or
current commercial sex activity in our study. Additionally,
the differences in prevalence can be caused by the differ-
ent recruitment procedures used in both studies. While we
performed a cross-sectional study, the Italian group used
a cohort design. The follow-up of drug addicts over years
usually requires patients in long-term contact with the
support system. Such patients in follow-up or treatment
settings might have a lower risk for the syphilis infection.
However, this hypothesis could be not corroborated by
our data, because we could not demonstrate a protective
effect of the participation in substitution programs on the
syphilis sero-status. An additional aspect is related espe-
cially to the infectious nature of syphilis. The Italian data
were based on an investigation in one city only. In our
study the prevalence of syphilis (TPHA positive tests)
ranged between 0% and 8.9% for the eight study centres.
This shows that syphilis may not spread efficiently
between clusters of drug addicts in different cities and it
may account for the differences between the Italian data
and our study.
Given the complexity of long term complications, our
estimate of prevalence does not provide sufficient infor-
mation for a cost-effectiveness analysis. An analysis by
Banger et al. supporting to abandon the general screening
strategy at admission to psychiatric hospitals was based
on 0.07% screening tests being positive [8]. Our data
show higher numbers of screening positives in this high
risk group setting compared to the study results of Banger
[8]. Thus, syphilis screening for this high risk group
should be favoured.
There are some important limitations to our study.
Because of the very low prevalence of positive FTA-ABS-
IgM tests confirming active syphilis, we had to use TPHA
positive cases for our analysis of risk factors, i.e. including
all patients with a past and current syphilis infection in
the same group. This requires the assumption that the
characteristics or behaviour of the patients with a past
infection still do reflect their risk status. With respect to
gender and women's sexual risk behaviour, the assump-Page 5 of 6
(page number not for citation purposes)
BMC Infectious Diseases 2005, 5:33 http://www.biomedcentral.com/1471-2334/5/33tion was corroborated by the agreement between risk pre-
diction based on TPHA and FTA-ABS-IgM. Nevertheless,
the failure to determine any further risk factors can be
caused by the misrepresentation of the risk factors in the
analysis based largely on patients who had syphilis in the
past. Some cases might have remained undetected (false
negative) but it is unlikely that this would be associated
with any particular risk factors. On the other side the false
positive cases would have the effect of diminishing esti-
mate of the true increased risk.
Conclusion
In conclusion our data underline the importance to screen
drug addicts in inpatient treatment settings for syphilis as
these patients represent a high risk group for sexually
transmitted diseases. In particular sexual active women
having high numbers of sexual partners were at highest
risk for syphilis infection. Especially infected prostitutes
may act as a multiplier in the dynamics of spread of infec-
tion into the heterosexual population.
The decision to abandon a general screening for syphilis
in many hospitals was to our knowledge neither based on
a formal cost-effectiveness analysis nor on the analysis of
the impact on the incidence of syphilis in a society. Taking
into account increasing numbers of syphilis cases world-
wide, we would suggest at least a screening for syphilis
among high risk opiate drug addicts in hospitals where
general screening for syphilis was abandoned. Further-
more, it might useful to suggest testing for gonorrhea and
chlamydia as well as for syphilis for people in drug treat-
ment programs as a significant amount of gonorrhea and
chlamydia is asymptomatic, especially in women.
Although we studied only the situation in Germany, sim-
ilar conditions may apply to other developed countries.
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